cbdMD (YCBD) EPS (Basic) Growth (1y) (2017 - 2026)
cbdMD (YCBD) EPS (Basic) Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 46.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.88% |
| Dec 31, 2025 | 97.92% |
| Sep 30, 2025 | 92.11% |
| Jun 30, 2025 | 82.35% |
| Mar 31, 2025 | 82.44% |
| Dec 31, 2024 | 67.90% |
| Sep 30, 2024 | 96.79% |
| Jun 30, 2024 | 87.07% |
| Mar 31, 2024 | 22.01% |
| Dec 31, 2023 | 81.75% |
| Sep 30, 2023 | 29.12% |
| Jun 30, 2023 | 95.30% |
| Mar 31, 2023 | 59.77% |
| Dec 31, 2022 | 76.45% |
| Sep 30, 2022 | -229.63% |
| Jun 30, 2022 | -3,291.57% |
| Mar 31, 2022 | 60.75% |
| Dec 31, 2021 | -91.41% |
| Sep 30, 2021 | 44.91% |
| Jun 30, 2021 | 109.78% |